verified SJR 1,178 · Q2 • database Scopus / SJR & Web of Science & DOAJ indexed

United Kingdom · BioMed Central Ltd

workspace_premium Q2 — Genetics verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ Unclaimed

BMC Cancer

BMC Cancer is a journal indexed in SJR in Genetics and Oncology with an H index of 171. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2390 €. The scope of the journal is focused on cancer. It has an SJR impact factor of 1,178 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,178.

BMC Cancer focuses its scope in these topics and keywords: cancer, breast, patients, cell, human, ovarian, study, expression, carcinoma, growth, ...

Editorial: BioMed Central Ltd

Category: Genetics

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guía para Autores (Guidelines)

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

1,178 Q2

H-index 171

Tasa de Aceptación pie_chart

22% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

19 semanas

Campo Average_time_publication_weeks

Coste de Publicación (APC) payments

2.390 € Open Access

Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science DOAJ

SJR Impact

1,178

H-index

171

Docs (year)

1560

Docs 3y

3894

Total refs

66847

Cites 3y

14266

Citable 3y

3888

Cites/Doc 2y

3.46

Ref/Doc

42.85

Immediate OA

2390 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review